Combination Chemotherapy in Treating Male Patients With Germ Cell Tumors

PHASE2CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

June 30, 2005

Study Completion Date

June 30, 2010

Conditions
Extragonadal Germ Cell TumorTeratomaTesticular Germ Cell Tumor
Interventions
BIOLOGICAL

bleomycin sulfate

DRUG

carboplatin

DRUG

cisplatin

DRUG

etoposide phosphate

DRUG

vincristine sulfate

Trial Locations (20)

B15 2TH

Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust, Birmingham

BS2 8ED

Bristol Haematology and Oncology Centre, Bristol

CB2 2QQ

Addenbrooke's Hospital, Cambridge

GL53 7AN

Gloucestershire Oncology Centre at Cheltenham General Hospital, Cheltenham

CV2 2DX

Walsgrave Hospital, Coventry

EX2 5DW

Royal Devon and Exeter Hospital, Exeter

LS9 7TF

Leeds Cancer Centre at St. James's University Hospital, Leeds

LE1 5WW

Leicester Royal Infirmary, Leicester

EC1A 7BE

Saint Bartholomew's Hospital, London

WIT 3AA

University College of London Hospitals, London

M20 4BX

Christie Hospital, Manchester

CH63 4JY

Clatterbridge Centre for Oncology, Merseyside

NG5 1PB

Nottingham City Hospital, Nottingham

PR2 9HT

Rosemere Cancer Centre at Royal Preston Hospital, Preston

RG1 5AN

Berkshire Cancer Centre at Royal Berkshire Hospital, Reading

SO16 6YD

Southampton General Hospital, Southampton

SM2 5PT

Royal Marsden - Surrey, Sutton

G11 6NT

Beatson West of Scotland Cancer Centre, Glasgow

1V2 3UJ

Raigmore Hospital, Inverness

CF14 2TL

Velindre Cancer Center at Velindre Hospital, Cardiff

Sponsors
All Listed Sponsors
lead

Medical Research Council

OTHER_GOV